A continuation of the double-blind, placebo-controlled study to determine the safety and efficacy of long-term (3 years) lamivudine (LAI) in patients with chronic hepatitis B virus (HBV).

View Statistics Email Alert RSS Feed

Grant Data
Project Title
A continuation of the double-blind, placebo-controlled study to determine the safety and efficacy of long-term (3 years) lamivudine (LAI) in patients with chronic hepatitis B virus (HBV).
Principal Investigator
Emeritus Professor Lai, Ching Lung   (Principal Investigator (PI))
Co-Investigator(s)
Professor Wu Pui Chee   (Co-Investigator)
Duration
60
Start Date
1996-01-01
Amount
0
Conference Title
A continuation of the double-blind, placebo-controlled study to determine the safety and efficacy of long-term (3 years) lamivudine (LAI) in patients with chronic hepatitis B virus (HBV).
Presentation Title
Keywords
null
Discipline
N/A
HKU Project Code
N/A
Grant Type
Other Funding Scheme
Funding Year
1995
Status
Completed